Previous 10 | Next 10 |
2024-01-05 05:17:06 ET Summary Anavex's Alzheimer's trial failed one of its two co-primary endpoints due to a faulty application of statistical analysis. The company's stock nearly doubled after publishing preclinical data on blarcamesine's effects on rats despite its limited rele...
ATLANTA, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Anavex Life Sciences Corp. (“Anavex” or the “Company”) (NASDAQ: AVXL) complied with federal securities laws. On January 2, 2024, Anavex announced topline results from the phase...
BOSTON, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Anavex Life Sciences Corp. (NASDAQ: AVXL) for potential securities law violations. Investors who have lost money in their Anavex Life Sciences Corp. investment should contact the firm to learn more about how they m...
NEW YORK, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders ...
2024-01-03 07:00:00 ET Summary The biotech industry experienced a challenging year in 2023 due to a rising 10-year Treasury yield. In 2024, the 10-year yield should favorably support biotech stocks. Promising advancements in weight loss drugs, neuroscience, oncology, and gene ...
2024-01-02 12:56:48 ET More on Mid-day movers & stocks. ENDRA Life Sciences Inc. (NDRA) Q3 2023 Earnings Call Transcript PolyPid Ltd. (PYPD) Q3 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Endra Life Sciences Historical earnings da...
2024-01-02 08:40:41 ET More on Anavex Life Sciences How Soon Might Anavex's Alzheimer's Drug Be Approved? The Good/Bad News Anavex Life Sciences: Rett Safety Dance With Broader CNS Implications (Rating Downgrade) Anavex Life Sciences Corp. (AVXL) Q4 2023 Earnings Cal...
2024-01-02 08:30:21 ET Losers: Corcept Therapeutics CORT -33% in patent battle with Teva . China SXT Pharmaceuticals ( SXTC ) -29% . Sentage Holdings ( SNTG ) -27% . China Green Agriculture ( CGA ) -23% . Aditxt ( ADTX ) -24% . ...
Anavex Announces Topline Results from Phase 2/3 EXCELLENCE Clinical Study in Pediatric Rett Syndrome Validation from Real World Evidence (RWE) of Rett Syndrome Patients under Compassionate Use Authorization NEW YORK, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp....
NEW YORK, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders ...
News, Short Squeeze, Breakout and More Instantly...
Anavex Life Sciences Corp. Company Name:
AVXL Stock Symbol:
NASDAQ Market:
Anavex Life Sciences Corp. Website:
U.S. stock futures were mixed this morning, with the Nasdaq futures gaining around 0.5% on Monday. Shares of GSK plc (NYSE:GSK) fell sharply in tod...
NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceuti...
NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative, neurodevelopmental, and neuropsyc...